title: Synergy between the pharmacological chaperone 1-deoxygalactonojirimycin and agalsidase alpha in cultured fibroblasts from patients with Fabry disease.
authors: Department of Public Health, Section of Nephrology, University of Naples Federico II, Naples, Italy.
authors: Antonio
authors: A
authors: Pisani
authors: Caterina
authors: C
authors: Porto
authors: Generoso
authors: G
authors: Andria
authors: Giancarlo
authors: G
authors: Parenti
mesh_terms: D017485:1-Deoxynojirimycin / Q000031:analogs & derivatives*; D000795:Fabry Disease / Q000201:enzymology* / Q000378:metabolism*; D005347:Fibroblasts / Q000378:metabolism*; D006801:Humans; D008297:Male; D011994:Recombinant Proteins / Q000378:metabolism*; D000519:alpha-Galactosidase / Q000378:metabolism*
chemical_list: D011994:Recombinant Proteins; D017485:1-Deoxynojirimycin; D000519:alpha-Galactosidase
references: Mol Ther. 2009 Jun;17(6):964-71
references: 19293774
references: J Inherit Metab Dis. 2012 May;35(3):513-20
references: 22187137